baber/WOPTO huggingface dataset:
Patent NZ-328982-A (NZ)
Title: Use of 9-dioxabicyclic or carbocyclic substituted purine derivatives for inhibiting tumour necrosis factor alpha activity
Inventor: BORCHERDING DAVID ROGER
IPC: A61K31/52
Filed: 1994-06-24
Abstract: A 9-dioxabicyclic or carbocyclic substituted purine derivative defined below or a pharmaceutically acceptable salt is used in the manufacture of a medicament for treating adult respiratory distress syndrome.  The 9-dioxabicyclic or carbocyclic substituted purine derivative has the formula 1, 2 or 3 wherein Y is nitrogen; Z1 and Z2 are independently H, halo or amino; A is a group of formula 4; X1, X2 and X3 are independently H, OH, N3, NH2, N(R)2, NHR, CN, CH2NH2, CONH2, CO2H, CH2OH, SH or SR and R is alkyl provided that: a)	at least one of X1, X2 and X3 is not than H; b)	when Z1 is NH2, Z2 is H or NH2, A is a group of formula 5, X1 is OH or H, X2 is H then X3 is not CO2H; c)	when Z2 is H, A is a group of formula 5, X1 is CO2H then Z1 is not a halo.
Patent NZ-329049-A (NZ)
Title: Allocating emergency speech items in a mobile communication system
Inventor: TARKIAINEN JANNE
IPC: H04W4/90
Filed: 1997-02-28
Abstract: A method for allocating emergency speech items in a mobile communication system comprising a network infrastructure (BS), a first subscriber station (MS1) connected to it, and at least one other subscriber station (MS2, MS3), the method comprising maintaining a group call consisting of speech items between the first subscriber station (MS1) and at least one other subscriber station (MS2), transmitting an emergency speech item demand (101) from the first subscriber station (MS1), which is in an emergency, to the network infrastructure (BS), and transmitting an emergency speech item grant message (102) from the network infrastructure to the first subscriber station. The method further comprises transmitting, to the at least one other subscriber station (MS2, MS3), emergency speech item information (103) containing the identifier of the first subscriber station (MS1) and indicating that an emergency speech item has been allocated (102) to the first subscriber station. In response to the emergency speech item information (103), the user of the at least one other subscriber station (MS2, MS3) is informed that an emergency speech item has been allocated (102) to the first subscriber station.
Patent NZ-336691-A (NZ)
Title: Expandable gastro-retentive therapeutic system with controlled active substance release in the gastro-intestinal tract
Inventor: ASMUSSEN BODO
IPC: A61D7/00
Filed: 1998-01-09
Abstract: The invention concerns a device for the controlled release of active substances in the gastro-intestinal tract with a retarded passage through the pylorus, the device comprising a component which can expand on contact with gastric juice and is surrounded by a polymer casing which is permeable to gastric juice and active substances. The device comprises at least one active substance in the form of a multi-particle preparation which releases the active substance into the gastric juice in retarded manner. The release of active substance from a device according to the invention can be controlled better than conventional medicaments with a retarded passage through the pylorus. Similarly, the device can easily be rolled or folded and inserted in capsules without difficulty.
Patent NZ-506312-A (NZ)
Title: Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one
Inventor: MOON KWANG YUL
IPC: C07D207/18
Filed: 1999-03-04
Abstract: A process for preparing a pyrrolidine of formula 1 wherein P1 and P2 are protecting groups comprises: a) reacting a compound of formula 5 with a Raney-nickel catalyst in a solvent under hydrogen to produce a compound of formula 6; b) protecting the amino group =CH-NH2 to produce a compound of formula 7 and c) selective reduction of the double bond of the =CH-NHP2 group to produce the pyrrolidine of formula 1.
Patent NZ-508050-A (NZ)
Title: Method of laser cutting stainless steel saw blades
Inventor: IZARD NOWELL WILLIAM
IPC: B23K26/08
Filed: 1999-05-06
Abstract: A method of manufacturing a tungsten carbide tipped circular saw blade (S) by: supplying a stainless sheet steel strip or blank to a laser cutting machine; laser cutting an arbour (11) and the periphery profile of the blade (S) according to a predetermined computer controlled pattern; brazing the tungsten carbide saw tips to their respective locations on the periphery of the blade (S); electro polishing the blade (S) to remove brazing residues and heat discolouration from the surfaces; and grinding the final cutting profile to each of the tungsten carbide tips.
Patent NZ-513742-A (NZ)
Title: Combinations of formoterol and mometasone furoate for asthma
Inventor: HASSAN IAN FRANCIS
IPC: A61K31/167
Filed: 2000-03-01
Abstract: A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or a solvate of the salt and (B) mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.
Patent NZ-514204-A (NZ)
Title: Direct central nervous system catheter and temperature control system
Inventor: MEYTHALER JAY M
IPC: A61M25/18
Filed: 2000-03-03
Abstract: A central nervous system (CNS) catheter assembly (20) adapted for use as a ventriculostomy catheter and a spinal catheter includes a catheter body (28) defining at least one lumen (30) there through having a drug delivery branch (22) and a monitoring/sensing branch (24). The drug delivery branch (22) and the monitoring/sensing second branch (24) are in fluid communication with the lumen (30). The assembly further includes a filter assembly (36) disposed in fluid communication with the drug delivery branch (22) and a valve assembly (54) disposed in fluid communication with the monitoring/sensing branch (24). Also in accordance with the present invention, there is provided a temperature control system (170) for use in controlling the temperature of a location within the central nervous system such as the brain or the spinal cord. The system further includes a pump controller (180), a central processing unit or controller (194), a temperature-sensing element (184), and a power supply (194) all operatively connected to the temperature control mechanism.
Patent NZ-515562-A (NZ)
Title: Pump chamber of enlarging cross-sectional area with piston having elastically deformable skirt member supported by rotatable stiff members on piston
Inventor: VAN DER BLOM NICOLAAS
IPC: F04B33/00
Filed: 1999-04-22
Abstract: The object of the invention is to provide a reliable and inexpensive combination of a chamber and a piston to be used in any device where such a combination is needed so that it complies with specific demands towards the operation force for e.g. pumps, specifically manually operated pumps. By a device comprising a chamber and a piston positioned inside the chamber said chamber and said piston relatively movable to each other in a predetermined direction of movement between a first position and a second position of which the cross-section of the chamber in a plane perpendicular to the direction of movement is larger at the first position than at the second position, the change in the cross section of the chamber is essentially continuous between the first position and the second position and the cross-section of the piston in a plane perpendicular to the direction of movement is arranged to adapt itself to the cross-section of the chamber. This is achieved by stiff support members 9.1, 9.2, 9.3, typically as a segmented spring washer, rotating through 10 to 40 degrees from the longitudinal axis 19 of the chamber 1 to seal elastically deformable means 8 against the inner wall of the chamber 1.
Patent NZ-521456-A (NZ)
Title: Macrocyclic NS3-Serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties
Inventor: VENKATRAMAN SRIKANTH
IPC: A61K38/08
Filed: 2001-04-17
Abstract: Disclosed are macrocyclic compounds of formula I, wherein the ring atoms are optionally substituted with hetero- atoms such as O, N or SO2. The compounds are used in the manufacture of medicaments for the treatment of disorders associated with HCV NS3 protease.
Patent NZ-521896-A (NZ)
Title: Serine protease inhibitors
Inventor: LIEBESCHUETZ JOHN WALTER
IPC: A61P9/10
Filed: 2001-06-12
Abstract: Disclosed are serine protease inhibitor compounds of formula (I), wherein Lp(D)n is a group of formula 2, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for the treatment of thrombotic disorders.
Patent NZ-522883-A (NZ)
Title: Lubricant coated steel for reinforced concrete column or bridge pier
Inventor: MUTSUYOSHI HIROSHI
IPC: E04C5/01
Filed: 2002-11-29
Abstract: A reinforced concrete column or bridge pier is disclosed, which comprises a plurality of deformed steel bars (14, 16) arranged in a longitudinal direction, and hoops (15, 17) arranged at desired intervals around the deformed steel bars (16) along the longitudinal direction, wherein a sheath (4) covers at least a portion of each deformed steel bar on which shear stress is exerted. Also disclosed is a reinforced concrete column or bridge pier is disclosed, which comprises a plurality of smooth round steel bars coated with lubricant and arranged in a longitudinal direction, and hoops arranged at desired intervals around the smooth round steel bars along the longitudinal direction. The sheath (4) as well as the lubricant covering the steel bars (3) is provided for the purpose of avoiding the adhesion between the steel bars and the concrete.
Patent NZ-524282-A (NZ)
Title: Opioid agonist/antagonist combinations in controlled release dosage form
Inventor: COLUCCI ROBERT D
IPC: A61K45/06
Filed: 2003-02-19
Abstract: An oral dosage form, comprising an orally therapeutically effective amount of an opioid agonist, and an opioid antagonist and a sustained release carrier, the dosage form having a ratio of opioid antagonist to opioid agonist that provides a combination product which is analgesically effective when the combination is administered orally, but which (i) is aversive in physically dependent human subjects when administered at the same dose or at a higher dose than the the therapeutically affective dose and (ii) maintains an analgesic effect but does not increase analgesic efficacy of the opioid agonist relative to the same therapeutic dose of opioid analgesic when administered to human patients without sthe opioid antagonist; the dosage form providing a release of the opioid agonist and antagonist indicative of twice-a-day therapy. Figure 1 shows naltrexone antagonism of hydrocodone-induced VAS (Visual Analogue Scale) "drug effect" for Example 1.
Patent NZ-525138-A (NZ)
Title: Phthalazinone derivatives for use as PARP inhibitors
Inventor: MARTIN NIALL MORRISON BARR
IPC: C07D237/32
Filed: 2001-10-25
Abstract: The use of the disclosed compounds to inhibit PARP activity.
Patent NZ-529706-A (NZ)
Title: Process for singulating cellulose fibers from a wet pulp sheet
Inventor: CRANE RAY
IPC: D21B1/06
Filed: 2003-11-21
Abstract: A hammermill for singulating cellulosic fibers from a wet pulp sheet includes a cylindrical housing, a feed slot with a breaker bar positioned therein and a rotor mounted for rotation in the housing. Feed rolls are provided to feed a sheet of pulp into the feed slot upstream of the breaker bar. A plurality of hammers are mounted on the rotor. Air is introduced into the hammermill housing tangentially downstream from the second feed slot. An air outlet is positioned tangentially on the housing downstream from the air inlet to allow air and singulated fibers to escape. A process for producing singulated fibers includes wetting a fiber sheet, milling the fibers in the hammermill, and drying the fibers. The singulated fibers have low knot content.
Patent NZ-534119-A (NZ)
Title: Metal cutting tool
Inventor: FRIEDMAN JACOB
IPC: B23B27/16
Filed: 2003-01-22
Abstract: A metal cutting tool (10) having an indexable cutting insert (12) retained in an insert pocket (16) of an insert holder (14). The cutting insert has two opposing side surfaces (24) with a peripheral edge surface (26) extending therebetween and a plurality of cutting portions (32). The peripheral edge surface (26) has a plurality of abutment sections (28), each abutment section (28) lying on a portion of a sidewall of an imaginary regular polygon. A plurality of cutting portions (32) extend outwardly from the imaginary polygon and are equal in number to the number of side walls thereof. Each abutment section (28) is located between two cutting portions (32). The insert holder (14) has an insert pocket (16) in which the cutting insert (12) is retained with the peripheral edge surface (26) being abutted at two abutment sections (28) by two support walls (20) of the insert pocket (16), the support walls (20) being fixed and integral parts of the insert holder(14).
Patent NZ-535136-A (NZ)
Title: Immobilized bioactive hydrogel matrices as surface coatings
Inventor: LAMBERTI FRANCIS V
IPC: A61L27/52
Filed: 2003-02-21
Abstract: A coated substrate comprises a substrate having a surface and a bioactive hydrogel matrix comprising a polyglycan, a polypeptide and at least one agent selected from polar amino acids and divalent cation chelators. The polyglycan and polypeptides are covalently attached to the surface of the substrate or entrapped within the surface of the substrate. The covalent attachment occurs by reaction of a reactive group carried by the polyglucan or polypeptide with a reactive group carried by the surface of the substrate. Preferably the substrate is a medical device, the polypeptide is dextran and the polyglycan a polysaccharide such as glycosamoinglycans or glucosaminoglycans. Also described is a method of producing the coated substrate.
Patent NZ-535989-A (NZ)
Title: Flavoured oil-in-water emulsions for food applications
Inventor: GELIN JEAN-LUC
IPC: A23L29/281
Filed: 2003-05-07
Abstract: An acidic butter oil-in-water emulsion of a lipophilic substance comprises 70-95% by weight relative to the total weight of the emulsion of a continuous aqueous phase and 5 to 30% by weight relative to the total weight of the emulsion of a dispersed phase. The aqueous phase comprises a combination of high methoxyl pectin and whey protein and the emulsion is capable of imparting, improving or modifying the flavour properties of a composition to which it is added. The combination of the HM pectin and whey protein stabilizes the butter oil-in-water emulsion which can be added to foodstuffs and beverages.
Patent NZ-536610-A (NZ)
Title: Spiro agonists and antagonists of M1 and M3 muscarinic receptors for treatment of central and peripheral nervous system disorders
Inventor: FISHER ABRAHAM
IPC: A61P13/10
Filed: 2003-05-01
Abstract: Disclosed is a compound of the formula (I) wherein the substituents are defined within the specification; or an enantiomer, diastereomer, racemate, tautomer, geometrical isomer, dimmer, or pharmaceutically acceptable salt thereof. Also disclosed is the use of the above compound or an enantiomer, diastereomer, racemate, tautomer, geometrical isomer, dimmer, or pharmaceutically acceptable salt thereof in the preparation of a pharmaceutical composition for stimulating the M1 muscarinic receptor and inhibiting the M3 muscarinic receptor.
Patent NZ-538124-A (NZ)
Title: Compact optical fibre cable
Inventor: BROWN GEORGE HENRY PLATT
IPC: G02B6/44
Filed: 2003-06-26
Abstract: A signal transmitting cable that has fibres 404 encapsulated by a UV curable layer 406 is described. Layer 406 has an outside diameter of 1010 microns. The UV curable material of the layer 406 does not penetrate into the gaps between the optical fibres and the outermost optical fibres 304 are restrained by the layer from moving axially. It is found that such an arrangement provides surprisingly favourable bending properties, making the cable particularly suitable for installation in a tube by means of blowing.
Patent NZ-548401-A (NZ)
Title: Stable liquid antihelmintic solution comprising triclabandazole dissolved in at least one solvent
Inventor: HARVEY COLIN MANSON
Filed: 2000-04-14
Abstract: Disclosed is a pour-on veterinary anthelmintic formulation containing one or more anthelmintic actives wherein one of the anthelmintic actives is triclabendazole in a stable liquid solution, wherein the solution contains at least 10% w/v of triclabendazole and a solvent system containing one or more of solvents selected from the group consisting of benzyl alcohol, glycerol formal, n-methyl-2-pyrrolidone, and glycol ethers and its use in treating parasites including liver flukes and fasciolisis in non-human animals.
Patent NZ-560399-A (NZ)
Title: Deodorizing method and apparatus for clothes or the like buy control of temperature and humidity
Inventor: NAKAMURA TAKAHARU
Filed: 2007-02-06
Abstract: A method for deodorizing clothes or the like is disclosed. The method comprises two steps A) a moisture- absorbing process followed by B) a deodorizing and drying process. The moisture- absorbing process includes the steps of inhaling air from ambient via a suction inlet (7a) into a housing (7) by an air blower (19) provided in the housing (7), generating cold air by cooling the air by a cooling apparatus (15) provided in the housing (7) and causing a to-be-conditioned article placed in a vicinity of a blowing outlet (7b) of the housing (7) to absorb moisture by blowing out the cold air from the blowing outlet (7b) for a predetermined time by the air blower (19). The deodorizing and drying process includes the steps of inhaling the air inside from the suction inlet (7a) of the housing (7) by the air blower (19) provided in the housing, generating heated air by heating the air by a heating apparatus (16) provided in the housing (7) and vaporizing the moisture containing an odour component by drying the to-be-conditioned article placed in the vicinity of the blowing outlet (7b) of the housing (7) by blowing out the heated air from the blowing outlet (7b) for a predetermined time by the air blower (19).
Patent NZ-564150-A (NZ)
Title: An OSH compliant packaging system for fruit
Inventor: TURNER JOHN CHARLES
Filed: 2006-03-03
Abstract: To pack fruit into cartons, the cartons then being stacked on pallets which are loaded into containers for delivery of the fruit to market, trays for the fruit are pre-selected from a defined set of trays to hold selected predefined weight bands of fruit of the crop, the fruit is packed into the pre-selected trays in accordance with the weight band of the fruit, and the packed trays are placed in the cartons so that each and every carton has a packed weight in a predetermined weight range, preferably 11.5 to 13 kg and always less than 14 kg gross laden carton weight per carton, irrespective of the weight band of the fruit placed in the carton.
Patent NZ-567325-A (NZ)
Title: Burner flashback detection and system shutdown apparatus
Inventor: PEART JACOB A
Filed: 2008-04-10
Abstract: Fuel-fired heating apparatus is provided. The fuel-fired heating apparatus comprises: a first burner having a body through which fuel may be flowed for combustion with air to create a flame emanating from the first burner; a second burner; and a fuel line structure. Fuel may be flowed through the fuel line structure to the second burner, where the fuel line structure has a portion which is openable in response to the body of the first burner reaching a predetermined elevated temperature indicative of a flame flashback condition therein. This permits fuel flowing through the fuel line structure to escape therefrom before reaching the second burner.
Patent NZ-570055-A (NZ)
Title: Coline salt of 4-(6-fluoro-3-oxo-1,3-dihydro-pyrazolo[4,3-c]cinnolin-2-yl)-N-(2,2-difluoro-ethyl)-benzamide
Inventor: MATTHEWS IAN RICHARD
IPC: A61K31/4162
Filed: 2007-02-19
Abstract: Disclosed is the choline salt of 4-(6-fluoro-3-oxo-1,3-dihydro-pyrazolo[4,3-c]cinnolin-2-yl)-N-(2,2-difluoro-ethyl)-benzamide of formula (A). Further disclosed is an orally administrable pharmaceutical composition containing the choline salt as defined above, and at least one pharmaceutically acceptable carrier.
Patent NZ-571998-A (NZ)
Title: Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol
Inventor: GEE-HONG KUO
IPC: C07D223/16
Filed: 2007-04-17
Abstract: The disclosure relates to benzoazepin-oxy-acetic acid derivatives of formula (I) as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol. These compounds are useful as PPAR agonists and are suitable for the treatment of one or more conditions selected from: diabetes, nephropathy, neuropathy, retinopathy, polycystic ovary syndrome, hypertension, ischemia, stroke, irritable bowel disorder, inflammation, cataract, cardiovascular diseases, Metabolic X Syndrome, hyper-LDL-cholesterolemia, dyslipidemia (including hypertriglyceridemia, hypercholesterolemia, mixed hyperlipidemia, and hypo-HDL-cholesterolemia), atherosclerosis, obesity, and other disorders related to lipid metabolism and energy homeostasis complications thereof.
Patent NZ-573033-A (NZ)
Title: Lock with foldable element and a retainer for securing wear member to earth-moving equipment
Inventor: MCCLANAHAN ROBERT
IPC: E02F9/28
Filed: 2007-06-13
Abstract: Disclosed is a lock (10) for securing wear member (12) to earth-moving equipment (14).The lock (10) includes an elongate foldable element with two ends (86 and 88) having a first position and a second position. In the first position the foldable element is in unfolded position and in a second position the foldable element is in folded position. The lock (10) also includes a retainer (76) that engages the foldable element and releasably holds the foldable element in the first position to resist the foldable element from moving to second position. During use, the lock (10) is inserted through an inlet into an opening (38) in the wear member (12). Once inserted the foldable element is retained in the unfolded position by the retainer (76). In this position, the two ends (86 and 88) of the foldable element extend beyond the inlet. The opposing side surfaces contacts the wall (90, 92) associated with the opening (38) in the wear member (12) and the rear face (40) on the earth -moving equipment (14). This position prevents the movement of the wear member (12) in a release direction and thus the wear member (12) will be secured to the earth-moving equipment (14). To release the wear member (12) from the earth-moving equipment (12), the foldable element is folded to the second position and is drawn outside from the opening (38).
Patent NZ-575800-A (NZ)
Title: Femoral component of posterior stabilized knee prosthesis and knee prosthesis having an arcuate shaped intercondylar portion.
Inventor: LIPMAN JOSEPH
IPC: A61F2/38
Filed: 2007-09-25
Abstract: 575800 A femoral component (110) for a knee joint prosthesis is disclosed. The femoral component comprises a body (112) having an anterior side and a posterior side and a pair of laterally spaced condylar portions (114, 116). An intercondylar portion (130) joins the condylar portions and includes a recess with an arcuate shaped roof (131) that is tangent to and extends between a pair of opposed parallel side walls. A knee joint prosthesis comprising such a femoral component (110) is also disclosed
Patent NZ-576307-A (NZ)
Title: Antimicrobial composition useful for preserving wood comprising tebuconazole, 5-chloro-2-methyl-4-isothiazolin-3-one, and 2-methyl-4-isothiazolin-3-one
Inventor: ASHMORE JOHN WILLIAM
IPC: A01N33/04
Filed: 2006-06-08
Abstract: Disclosed is a synergistic antimicrobial composition comprising tebuconazole, 5-chloro-2-methyl-4-isothiazolin-3-one, and 2-methyl-4-isothiazolin-3-one. Also described is the use of the composition to inhibit the growth of microorganisms. (62) Divided Out of 563783